Angle Share News (AGL)

Angle Information

Buy AGL Shares
Add AGL to Watchlist
Add AGL to Alert

Share Price Information for Angle (AGL)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 17.75

Bid: 17.00

Ask: 18.50

Change: 0.00 (0.00%)

Spread: 1.50 (8.824%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 17.75

Last checked at -

UPDATE: Angle Successfully Raises GBP20 Million In Placing

Tue, 27th Oct 2020 19:06

(Alliance News) - Angle PLC on Tuesday said it raised GBP19.6 million through a placing.

The liquid biopsy company placed 42.6 million shares at 46 pence each, a 5.2% discount to its 48.5p closing price on Monday.

Angle shares closed 0.3% lower at 48.38p each in London on Tuesday.

Proceeds will go towards funding ongoing operations, as well as building new clinical laboratories for pharmaceutical services, and commercial expansion including sales and partnerships, Angle explained earlier on Tuesday.

By Eric Cunha; ericcunha@alliancenews.com

More News

14 Aug 2020 12:41

Angle's Parsortix Able To Predict Patients' Response To Treatment

20 Jul 2020 20:03

IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix

20 Jul 2020 10:16

Angle's 'Parsortix' advantageous in breast cancer in new research

(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertaken in metastatic breast cancer (MBC), highlighting advantages of a 'Parsortix' liquid biopsy, compared to standard-of-care tissue biopsy.

25 Jun 2020 12:22

Angle Progresses On Parsortix And De Novo Clearance From US Regulator

18 Jun 2020 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

10 Jun 2020 16:41

IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board

12 May 2020 18:54

Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects

12 May 2020 08:58

Angle upbeat on recent research using 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago in Spain has published results of new work undertaken in head and neck cancer and non small cell lung cancer, on the potential utility of a liquid biopsy-based strategy to assess MET alterations on circulating tumour cells (CTCs).

28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

28 Apr 2020 10:03

Angle works with skeleton R&D crew during lockdown

(Sharecast News) - Biopharmaceuticals group Angle said on Tuesday that progress had been impeded by the Covid-19 outbreak as the firm worked with a research and development skeleton crew in Guildford.

31 Mar 2020 12:21

UK TRADING UPDATE SUMMARY: Synairgen Starts Covid-19 Treatment Trial

31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Latest Share Chat

Angle Share News (AGL)

Share Price Information for Angle (AGL)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Angle Successfully Raises GBP20 Million In Placing

Login to your account

Quickpicks are a member only feature

Login to your account